GSTO2
Basic information
Region (hg38): 10:104268873-104304950
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (27 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSTO2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000183239.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 27 | 1 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSTO2 | protein_coding | protein_coding | ENST00000338595 | 6 | 36073 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.61e-9 | 0.0839 | 125575 | 0 | 173 | 125748 | 0.000688 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.309 | 126 | 136 | 0.925 | 0.00000691 | 1594 |
Missense in Polyphen | 39 | 42.46 | 0.91852 | 534 | ||
Synonymous | 1.04 | 41 | 50.4 | 0.814 | 0.00000237 | 454 |
Loss of Function | -0.0896 | 13 | 12.7 | 1.03 | 6.32e-7 | 154 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00115 | 0.00115 |
Ashkenazi Jewish | 0.000398 | 0.000397 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000902 | 0.000897 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000753 | 0.000752 |
Other | 0.000818 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits glutathione-dependent thiol transferase activity. Has high dehydroascorbate reductase activity and may contribute to the recycling of ascorbic acid. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA). {ECO:0000269|PubMed:15970797}.;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Gamma-glutamyl-transpeptidase deficiency;5-oxoprolinase deficiency;Gamma-Glutamyltransferase Deficiency;Glutathione Metabolism;Glutathione Synthetase Deficiency;5-Oxoprolinuria;Metapathway biotransformation Phase I and II;Glutathione conjugation;Phase II - Conjugation of compounds;Vitamin C (ascorbate) metabolism;glutathione-mediated detoxification;Biological oxidations;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.259
Intolerance Scores
- loftool
- 0.641
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- 0.0802
- hipred
- N
- hipred_score
- 0.131
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0434
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gsto2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- xenobiotic metabolic process;L-ascorbic acid metabolic process;oxidation-reduction process;cellular response to arsenic-containing substance;cellular oxidant detoxification;glutathione derivative biosynthetic process
- Cellular component
- cytosol;extracellular exosome
- Molecular function
- glutathione transferase activity;protein binding;oxidoreductase activity;identical protein binding;glutathione dehydrogenase (ascorbate) activity;methylarsonate reductase activity